Case Report {#sec1_1}
===========

A woman in her 60s was referred to our clinic after the fourth recurrence in 3 months of a histologically confirmed keratoacanthoma (KA). The lesion had been resected three times and grafted. Examination revealed a firm, skin-coloured, centrally keratin-filled dome-shaped nodule on the back of the left hand (fig [1a](#f1){ref-type="fig"}). The patient was Fitzpatrick skin type II with marked bilateral photodamage on forearms and hands. Histology of previous biopsies showed well-differentiated squamous cell carcinomas (SCCs) reminiscent of KA with acanthotic epidermis, enlarged keratinocytes in the basal and spinous layers and keratinized areas with a pale glassy cytoplasm and hyperkeratosis surrounded by inflammatory infiltrates of neutrophils and eosinophils (fig [2](#f2){ref-type="fig"}).

The patient refused further surgical intervention at this time and was treated instead with conventional radiotherapy on the left hand (energy 50 kV in 12 fractions with a total dose of 48 Gy). Within 1 month after the end of radiotherapy, the tumour recurred around the radiotherapy field (fig [1b](#f1){ref-type="fig"}) and two new tumours appeared on the extensor surface of the right arm. Histological examination of recurring and new lesions (fig [2](#f2){ref-type="fig"}) showed a picture identical to the previous biopsies and the tumours were interpreted as KA. Based on this recent history of recurrent KA, multiple self-healing squamous epithelioma (MSSE) Ferguson-Smith was suspected \[[@B1]\]. Mutation analysis of genomic DNA from blood revealed a p.Arg80X nonsense mutation (c.238C\>T) in exon II of the transforming growth factor beta receptor 1 gene *(TGFBR1)*, as described in other MSSE patients \[[@B2]\] confirming the diagnosis despite negative family history and late appearance of the first KA in the 7th decade.

The patient then agreed to minimal surgical intervention combined with intralesional injections of triamcinolone acetate, which induced rapid healing of the three lesions (fig [1c](#f1){ref-type="fig"}). Neither lesion recurred over a 4-year follow-up.

Comparison between mature (fig [2a, b](#f2){ref-type="fig"}) and spontaneously regressed (fig [2c, d](#f2){ref-type="fig"}) KA using haematoxylin and eosin and staining with CD123 plasmacytoid dendritic cell surface marker revealed a strongly increased inflammatory infiltrate with numerous plasmacytoid dendritic cells in the regressing KA versus the mature one.

Discussion {#sec1_2}
==========

Morphologically close to cutaneous SCC, KA is a benign tumour, rapidly growing over 4--5 weeks before spontaneous regression over weeks or months, leaving a scar \[[@B1]\]. KAs are usually solitary lesions, but multiple forms exist like the MSSE, or Ferguson-Smith disease, an autosomal-dominant genodermatosis. The origin and behaviour of KA is controversial: KA is sometimes classified as a variant of SCC, sharing local destructive and metastatic capacity \[[@B3]\]. Others consider KA as a distinct entity due to its particular histology and spontaneous regression \[[@B4], [@B5], [@B6]\]. Recent evidence suggests that the gatekeeper mutations underlying the two may be different. The causal TGFBR1 mutations in multiple KA of MSSE/Ferguson-Smith disease \[[@B2]\] contrast with the Notch 1/2 gatekeeper mutations in SCC \[[@B7]\]. Further studies are needed to determine whether this is a consistent fundamental distinction between SCC and all KA.

In general, TGF-beta signalling is considered to function as a tumor suppressor in early tumorigenesis and a promoter in late stages. Therefore, the reversal of this paradigm in MSSE, with initial growth and subsequent regression, is not surprising. Similarly, injection of corticosteroids in MSSE may have paradoxical effects with action on the proliferation phase rather than the inflammatory regression phase of the KA. The presence of abundant plasmacytoid dendritic cells in KA compared to cutaneous SCC has been reported \[[@B8]\], but the comparison between regressed and mature KA has not been described yet. Triggering of multiple KA after imiquimod treatment \[[@B9]\] and radiotherapy \[[@B10]\] has been reported.

Our case confirms that radiotherapy exacerbates MSSE and should be avoided. This and the late occurrence of the KA in sun-exposed skin indicate that supplementary driving factors are necessary for MSSE-type KA tumorigenesis besides the primary genomic *TGFBR1* mutations. Also, this particular type of KA responds well to excision and corticosteroid prevention of recurrence. Intralesional triamcinolone acetate injection is a safe and easy to use method as reported in older articles \[[@B11]\], especially in patients with contraindications to extensive and repeated surgery, also effective for multiple lesions. Our case underlines the difference between SCC and KA, responding differently to therapies like imiquimod or radiotherapy.
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![Clinical pictures before and after treatment. **a** Patient at presentation with the fourth recurrence in 3 months of a skin lesion on the back of the left hand. **b** Recurrence after radiotherapy. **c** Cure after intralesional injections of triamcinolone acetate.](cde-0008-0344-g01){#f1}

![Histological pictures of keratoacanthoma. Haematoxylin and eosin stain (**a**) as well as CD123 staining (**b**) of a mature keratoacanthoma. Haematoxylin and eosin stain (**c**) as well as CD123 staining (**d**) of a keratoacanthoma in regression.](cde-0008-0344-g02){#f2}
